title: Novel tyrosine kinase inhibitors in the treatment of cancer.
authors.affiliation: Drug Development Program, Princess Margaret Hospital, Toronto, Canada. alberto.ocana@uhn.on.ca
authors.forename: Alberto
authors.initials: A
authors.lastname: Ocana
authors.forename: Rosario
authors.initials: R
authors.lastname: Serrano
authors.forename: Raul
authors.initials: R
authors.lastname: Calero
authors.forename: Atanasio
authors.initials: A
authors.lastname: Pandiella
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases